| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Sable Kyle | Chief Financial Officer | C/O PERIMETER SOLUTIONS, INC., 8000 MARYLAND AVE., SUITE 350, CLAYTON | /s/ Noriko Yokozuka, as Attorney-in-Fact | 02 Mar 2026 | 0002001580 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PRM | Stock Option (right to buy) | Award | $0 | +50,000 | +100% | $0.000000 | 100,000 | 26 Feb 2026 | Common Stock | 50,000 | $13.24 | Direct | F1 |
| transaction | PRM | Stock Option (right to buy) | Award | $0 | +20,000 | $0.000000 | 20,000 | 26 Feb 2026 | Common Stock | 20,000 | $3.89 | Direct | F2 | |
| transaction | PRM | Stock Option (right to buy) | Award | $0 | +100,000 | +50% | $0.000000 | 300,000 | 26 Feb 2026 | Common Stock | 100,000 | $8.36 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | On September 27, 2024, the reporting person was granted an option to purchase 250,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 50,000 shares of common stock. |
| F2 | On November 16, 2023, the reporting person was granted an option to purchase 100,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 20,000 shares of common stock. |
| F3 | On May 6, 2022, the reporting person was granted an option to purchase 500,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 100,000 shares of common stock. |